A large study adds to evidence that the main ingredient in Novo Nordisk's injectable GLP-1 drug for type 2 diabetes may ...

Vasan Eye Care continues to pave the way for better vision and overall improved quality of life for everyone ...

Although the prevalence of diabetes-related eye diseases has almost doubled since ... but the data hasn't caught up to these new patients, meaning that a future tsunami of vision-threatening ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may increase patients’ risk for a dangerous eye condition. The findings about ...

Although the prevalence of diabetes-related eye diseases almost doubled since 2014 ... but the data hasn't caught up to these new patients, meaning that a future tsunami of vision-threatening ...

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide ... The higher risk of developing the sight-threatening eye problem known as nonarteritic anterior ischemic ...